Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
17 results
D2.19 - Can Drug Provocation Be Avoided in Low-Risk Quinolone Reactions?
D2.17 - Diagnostic profitability of penicilloyl-polylysine and minor determinant mixture in urgent/preferred beta-lactam allergy studies in hospitalized patients from january 2023 to december 2025
D2.20 - Selective Fixed Drug Eruption from Etoricoxib with Safe Celecoxib Use: Role of Patch Testing
D2.21 - The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity
D2.29 - Use and knowledge of Phadiatop Infant and Fx5 in children from a primary care healthcare area
D3.288 - Evaluating the role of dust mite sensitization in the development of edible insect allergies
D3.289 - Tolerance Assessment in Children with IgE-Mediated Cow's Milk Allergy Using Different Cutoff Values of Cow’s Milk Specific IgE
D3.284 - Milk Aversion After Successful Desensitization in a Milk-Allergic Child
D3.283 - Oat-Induced Anaphylaxis: Allergenic Characterization in a Clinical Case
D3.286 - Infant feeding patterns, perinatal history and the development of food allergy in early childhood
D3.287 - Tick Bite–Induced Alpha-Gal Syndrome: A Report of Two Cases and Literature Review Focusing on Clinical Characteristics of Asian Patients
D3.291 - Molecular Identification of Heat-Stable β-Parvalbumin in megrim (Lepidorhombus boscii) as the Likely Allergen in a Child With Selective Fish Reactivity
D3.292 - Safety profile of the yellow fever vaccine in egg-allergic children
D3.455 - Comparative Characterization of Olfactory Dysfunction in Mouse Models of Eosinophilic Chronic Rhinosinusitis
D3.456 - BEAMER: A multidisciplinary model for disease-agnostic adherence integrating chronic rhinosinusitis: development and prospective study
D3.454 - Do we still need aspirin desensitization therapy for nasal polyposis?
D3.462 - Polysorbate 80 (E433) sensitisation predicts and explains part of the variability of the Chronic Cough and Opposing Defiant Behaviour (ODB) in sensitised children: how the industrialised nutrition impacts the gut-brain axis and favours neuro-inflammation
Download the app
The congress at your fingertips
Available on
Download